SIRT1 and SIRT2 mediate renal interstitial fibroblast activation, proliferation, and advancement of renal fibrogenesis, indicating that SIRT1 and SIRT2 inhibitors may be helpful for the treatment of CKD. This evidence concerns the gene SIRT1 and chronic kidney disease.